A practical reference on IGF-1: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-03-17. Anything still debated is marked as such rather than presented as settled.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
| Property | Value | Notes |
|---|---|---|
| Primary target | GHRH receptor | Present on pituitary somatotroph cells |
| Signal pathway | Gs, cyclic AMP, protein kinase A | Sequence follows receptor activation |
| Main measured effect | Growth hormone release | Insulin-like growth factor 1 shifts indirectly |
| Half-life, binding form | Several days | Extended through serum albumin association |
| Half-life, unmodified form | About 30 minutes | Limited mainly by enzymatic cleavage |
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography combined with mass spectrometry. The chromatographic separation resolves the target peptide from truncation products and from species carrying oxidised residues, while mass measurement confirms the expected molecular mass. Because the two common variants differ by roughly 280 daltons, a mass determination distinguishes them unambiguously. Purity is often quoted as a percentage of total peak area, although that figure depends on the detection wavelength and the integration method applied.
Reported half-lives differ widely between the two variants and between species. Values for the albumin-binding form are usually expressed in days, while the unconjugated form is measured in minutes to a few hours. Sampling schedules, assay sensitivity, and route of administration all influence the numbers, which limits direct comparison across studies. Whether sustained receptor occupancy produces different downstream effects from pulsatile stimulation remains an open question in the published work. Claims about relative potency should therefore be read alongside the specific study design that produced them.
Lyophilised powder is the usual supplied form. The material is hygroscopic, so vials are typically equilibrated to room temperature before opening in order to prevent condensation on the contents. Long-term storage is generally described at minus twenty degrees Celsius or colder, protected from light and moisture. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of soluble material. A reconstituted solution is considerably less stable than the dry powder and is normally kept refrigerated for short periods only.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
=== Pharmacodynamics === Methylestradiol is an estrogen, or an agonist of the estrogen receptor. It shows somewhat lower affinity for the estrogen receptor than estradiol or ethinylestradiol. Methylestradiol is an active metabolite of the androgens/anabolic steroids methyltestosterone (17α-methyltestosterone), metandienone (17α-methyl-δ1-testosterone), and normethandrone (17α-methyl-19-nortestosterone), and is responsible for their estrogenic side effects, such as gynecomastia and fluid retention.
Eating much faster than normal, perhaps in a short space of time Eating until feeling uncomfortably full Eating a large amount even when not hungry Subjective loss of control over how much or what is eaten Planning and allocating specific times for bingeing Eating alone or secretly Not being able to remember what was eaten after the binge Feelings of guilt, shame, or disgust following a food binge Body image disturbance In contrast to bulimia nervosa, binge eating episodes are not regularly followed by activities intended to compensate for the amount of food consumed, such as self-induced vomiting, laxative or enema misuse, or strenuous exercise. BED is characterized more by overeating than dietary restriction. Those with BED often have poor body image and frequently diet, but are unsuccessful due to the severity of their binge eating. Obesity is common in persons with BED, as are depression, low self-esteem, stress and boredom. Regarding cognitive abilities, individuals showing severe binge eating symptoms may experience small dysfunctions in executive functions. Those with BED are also at risk of non-alcoholic fatty liver disease, menstrual irregularities such as amenorrhea, and gastrointestinal problems such as acid reflux and heartburn.
Sensory gating A process by which the brain filters out redundant or unnecessary stimuli from all the sensory inputs, often studied in schizophrenia research. Sensory map An organized representation of sensory information in the brain. For example, the somatotopic map in the primary somatosensory cortex. Serotonin A neurotransmitter involved in mood, sleep, appetite, and cognition. Dysregulation of serotonin systems is linked to depression and anxiety disorders. Short-term memory The capacity to hold a small amount of information in an active, readily accessible state for a short period of time. Often contrasted with long-term memory. Sleep spindle A burst of oscillatory brain activity visible on an EEG during Stage 2 non-REM sleep. Thought to play a role in memory consolidation. Somatic nervous system A component of the peripheral nervous system responsible for voluntary control of body movements via skeletal muscles. Somatosensory system The part of the sensory system concerned with the conscious perception of touch, pressure, pain, temperature, position, movement, and vibration. Spasticity A condition of increased muscle tone (hypertonia) and exaggerated reflexes, often resulting from damage to upper motor neurons. Spatial memory The part of memory responsible for recording information about one’s environment and spatial orientation. Heavily dependent on the hippocampus. Spike-timing-dependent plasticity (STDP) A form of synaptic plasticity in which the timing of neuronal spikes determines whether synapses are strengthened or weakened.
Another method of possible remediation for CEC is through the use of membrane bioreactors (MBRs) that act through mechanisms of sorption and biodegradation. Membrane bioreactors have shown results on being able to filter out certain solutes and chemicals from wastewater through methods of microfiltration, but due to the extremely small size of CEC, MBRs must rely on other mechanisms in order to ensure the removal of CEC. One mechanism that MBRs use to remove CEC from wastewater is sorption. Sorption of the CEC to sludge deposits in the MBR's system can allow the deposits to sit and be bombarded with water, causing the eventual biodegradation of CEC in the membrane. Sorption of a particular CEC can be even more efficient in the system if the CEC is hydrophobic, causing it to move from the wastewater to the sludge deposits more quickly.
Sources: en.wikipedia.org
Guzmán G. (1983). The genus Psilocybe: A Systematic Revision of the Known Species Including the History, Distribution and Chemistry of the Hallucinogenic Species. Nova Hedwigia Beihefte. Vol. 74. Berlin: J. Cramer. ISBN 978-3-7682-5474-8. Bresinsky A, Besl H (1989). A Colour Atlas of Poisonous Fungi: a Handbook for Pharmacists, Doctors, and Biologists. London, UK: Manson Publishing Ltd. ISBN 978-0-7234-1576-3. Stamets P. (1996). Psilocybin Mushrooms of the World: An Identification Guide. Berkeley, California: Ten Speed Press. ISBN 978-0-89815-839-7. Gartz J. (1997). Magic Mushrooms Around the World. Los Angeles, California: LIS Publications. ISBN 978-0-9653399-0-2.
In the 2017 chief executive election, Carrie Lam was victorious, reportedly with the endorsement of the CCP Politburo. Xi supported the Hong Kong Government and Carrie Lam against the protesters in the 2019–2020 Hong Kong protests, which broke out after a proposed bill that would allow extraditions to mainland China. He defended the Hong Kong Police Force's use of force, saying that "We sternly support the Hong Kong police to take forceful actions in enforcing the law, and the Hong Kong judiciary to punish in accordance with the law those who have committed violent crimes." While visiting Macau on 20 December 2019 as part of the 20th anniversary of its return to China, Xi warned of foreign forces interfering in Hong Kong and Macau, while also hinting that Macau could be a model for Hong Kong to follow. In 2020, the NPCSC passed a national security law in Hong Kong that dramatically expanded government clampdown over the opposition in the city; amongst the measures were the dramatic restriction on political opposition and the creation of the Office for Safeguarding National Security outside Hong Kong jurisdiction to oversee the enforcement of the law. Xi visited Hong Kong as Chinese leader in 2017 and 2022, in the 20th and 25th anniversary of the handover of Hong Kong respectively. During his 2017 visit to Hong Kong, Xi swore in Lam as chief executive. In his 2022 visit, he swore in John Lee Ka-chiu as chief executive, a former police officer that was backed by the Chinese government to expand control over the city.
=== Direct-to-consumer === Direct-to-consumer tests are regulated as medical devices, although they are not necessarily reviewed by the FDA. 23andMe direct-to-consumer genetic tests were originally offered as LDTs, but the FDA challenged that and forced the company to submit the test for approval as a class II medical device.
=== Acid derivatives === The formation of amide is promoted by CDI. Although the reactivity of CDI is less than acid chlorides, it is more easily handled and avoids the use of thionyl chloride in acid chloride formation, which can cause side reactions. An early application of this type of reaction was noted in the formation of peptide bonds (with CO2 formation as a driving force). The proposed mechanism for the reaction between a carboxylic acid and CDI is presented below.
=== Parenting === While there is no direct evidence of Tyrannosaurus raising their young (given the rarity of juvenile and nest Tyrannosaur fossils), it has been suggested that like its closest living relatives, birds and crocodiles, Tyrannosaurus may have protected and fed its young. Crocodilians and birds are often suggested by some paleontologists to be modern analogues for dinosaur parenting. Direct evidence of parental behavior exists in other dinosaurs such as Maiasaura peeblesorum, the first dinosaur to have been discovered to raise its young, as well as more closely related Oviraptorids, the latter suggesting parental behavior in theropods. Some very young specimens assigned to Tyrannosaurus rex suggest that, although the species may have provided parental care, it was likely limited.
Sources: en.wikipedia.org
==== Absorption ==== Propranolol is rapidly and completely absorbed, with peak plasma levels achieved about 2 hours (range 1–3 hours) after ingestion. Its oral bioavailability is approximately 25%. Despite complete absorption, propranolol has a variable bioavailability due to extensive first-pass metabolism. Hepatic impairment therefore increases its bioavailability. Therapeutic plasma concentrations are typically between 0.02 and 0.3 mg/L. Toxicity has been reported at concentrations of 1 mg/L and above, with coma or death associated with concentrations of 4 to 10 mg/L and above. Coadministration with food appears to enhance bioavailability but does not hasten its time to peak levels. Propranolol can be absorbed along the whole intestine with the main absorption site being the colon, which means people who have lost their colon due to surgery may absorb less propranolol. Propranolol shows marked interindividual variability in pharmacokinetics, with propranolol levels varying 20-fold in different individuals.
His suicide and the deaths of two other former child actors would inspire the founding by former child actor Paul Petersen of the advocacy and support group A Minor Consideration in 1990. Jenő Ghyczy, 88, Hungarian Foreign Minister from 1943 to 1944
=== Combined elementary and middle schools === Pre-kindergarten through grade 8 schools are essentially combined elementary and middle schools, facilitated in one building. Most of these schools are referred to as "academies" in the school district. The elementary school usually starts at pre-kindergarten and ends at grade 5 and the middle school starts at grade 6 and ends at grade 8. These schools usually offer a slightly enhanced standard of learning and studies have suggested that students have benefited from being in one continuous facility from kindergarten through 8th grade, without having the disruption having to attend a brand new school, for the middle school years. Cora L. Rice Elementary School and G. James Gholson Middle School are not true academies. Both schools are housed in one facility but they operate as two completely separate schools for all intents and purposes.
=== Final weeks on the Gulf Coast === Filming resumed on July 19. The sandpit fight scene between Bosworth and pro wrestler Tom Magee was shot in Bay St. Louis. It was aborted after a first attempt where Bosworth clipped Magee's cheek with a punch, and finished two weeks later on August 9. While a King Features gossip column claimed that the botch had led to a real scuffle, Bosworth himself assured that the accident had been handled in a civil manner by both. The final scene shot on the Gulf Coast was a gas station explosion on Daisy Vestry Road in Latimer on August 10.
== History == 2C-B was first synthesized and evaluated by American chemist Alexander Shulgin in 1974. He described the properties and effects of 2C-B in humans, along with those of 2C-D, in the scientific literature in 1975. Shulgin proposed 2C-B and 2C-D for use in psychedelic-assisted psychotherapy. However, it was reportedly abandoned for such purposes due to gastrointestinal side effects and lack of entactogenic effects. 2C-B was Shulgin's favorite psychedelic of his own creations, though he has said that he only tried it a few times.
Sources: en.wikipedia.org
It acts on the growth hormone-releasing hormone receptor found on pituitary somatotroph cells. Activation of that receptor triggers growth hormone release through a cyclic AMP dependent pathway.
It links the peptide to serum albumin after administration, which delays removal from circulation. Reported half-life shifts from roughly half an hour to several days as a result.
Most published work tracks serum growth hormone and insulin-like growth factor 1 over time. Sampling schedules and assay methods vary enough that figures are not directly comparable across reports.
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.